Samuel P. Wertheimer - 26 Jan 2023 Form 4 Insider Report for Apexigen, Inc.

Role: Director
Signature: /s/ Francis Sarena, by power of attorney
Issuer symbol: N/A
Transactions as of: 26 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 23 May 2023, 19:38:39 UTC
Previous filing: 03 Oct 2022
Next filing: 25 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APGN	Common Stock	Other	$0	+146,383		$0.000000	146,383	26 Jan 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APGN	Common Stock Warrants (right to buy)	Other	$0	+12,383		$0.000000	12,383	26 Jan 2023	Common Stock	12,383	$11.50	Direct	F1
transaction	APGN	Common Stock Warrants (right to buy)	Other	$0	+1,845		$0.000000	1,845	21 Feb 2023	Common Stock	1,845	$1.75	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the receipt of shares and warrants pursuant to an in-kind distribution by Brookline Capital Holdings, LLC without consideration to its partners.
F2	The warrants were acquired pursuant to a transfer not for value from Brookline Capital Markets, for which the reporting person serves as a Managing Partner and Senior Scientific Advisor.